Enhancement of nasal absorption of acyclovir via cyclodextrins

Journal of Inclusion Phenomena

Volumn 44, Issue 1-4, 2002, Pages 137-140

  Chavanpatil, M ^a   Vavia, P R ^a  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Acyclovir; Cyclodextrins; Nasal solutions

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ACICLOVIR; ALPHA CYCLODEXTRIN; BETA CYCLODEXTRIN; CYCLODEXTRIN DERIVATIVE; GAMMA CYCLODEXTRIN; METHYL BETA CYCLODEXTRIN;

CONCENTRATION RESPONSE; CONFERENCE PAPER; DRUG ABSORPTION; DRUG DEGRADATION; IN VITRO STUDY; NONHUMAN; PERFUSION; PH; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0345765004     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023030210154     Document Type: Conference Paper

References (13)

1. A.A. Hussain: Adv. Drug Delivery Rev. 29, 39 (1998).
2. R. Krishamoorthy and A.K. Mitra: Adv. Drug Delvery Rev. 29, 135 (1998).
3. J. O'Brien and D. Campoli-Richards: Drugs 37, 233 (1989).
4. Z. Shao and A.K. Mitra: Int. J. Pharm. 11, 243 (1994).
5. A.H. Shojaei and B. Berner: Pharm. Res. 15, 1182 (1998).
6. S. Hirai, T. Yashiki, T. Matsuzaw, and H. Mima: Int. J. Pharm. 7, 317 (1981).
7. C. Huang, R. Kimura, R. Bawarshi-Nassar, and A. Hussain: J. Pharm. Sci. 74, 608 (1985).
8. A. Martin, G. Bankar, and A Chun: in H. Bean, A. Beckett and J. Cartess (eds.), Advances in Pharmaceutical Sciences, Chapter 21 (1964).
9. S. Hira, T. Ikenaya, and T. Mtsuzawa: Diabetes 27, 296 (1978).
10. M. Hayashi, T. Hirasawa, T. Muraoka, and M. Shiga: Chem. Pharm. Bull. 33, 2149 (1983).
11. A. Fisher, K. Broun, S.Davis, and G. Parr: J. Pharm. Pharmacol. 39, 357 (1987).
12. M. Donovan, G. Flynn, and G. Amidon: Pharm. Res. 7, 863 (1990).
13. F. Merkus, J. Verhoef, S. Romeijn, and N. Schipper: Pharm. Res. 8, 588 (1991).